• Most Popular
  • Most Shared

MedImmune's FluMist benefits some young kids-panel

Wed May 16, 2007 1:31pm EDT

GAITHERSBURG, Md., May 16 (Reuters) - The benefits of MedImmune Inc.'s MEDI.O FluMist influenza vaccine outweigh any possible risks for some younger children, a U.S. advisory panel said on Wednesday.

Regulatory News

The Food and Drug Administration's panel of outside experts, in a 9-6 vote, found the nasal spray was beneficial for 1- to 5-year-olds. But the panel saw less benefit in children as young as 6 months old.

MedImmune is seeking wider approval for the vaccine, which is already approved for 5- to 49-year-olds.

Regulatory News


More from Reuters

Pro Life Democrat Rep. Bart Stupak holds an Executive Order from U.S. President Barack Obama claiming no money from passage of the health care bill will be used for abortion while on Capitol Hill in Washington, March 21, 2010. At left is Rep. Kathleen Dahlkemper (D-Pa). REUTERS/Larry Downing

Healthcare overhaul headed for passage

House Democrats neared passage of a healthcare bill that would create the biggest policy changes in decades and hand President Obama a landmark victory.  Full Article | Video 

Healthcare reform
A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    Afghanistan
    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article 

      Pharmaceuticals